These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15622180)

  • 1. What does a B-type natriuretic peptide test show?
    Kim J
    Nursing; 2005 Jan; 35(1):26. PubMed ID: 15622180
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers in heart failure management.
    Isaac DL
    Curr Opin Cardiol; 2008 Mar; 23(2):127-33. PubMed ID: 18303525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-type natriuretic peptide in the management of heart failure.
    Maurellet JD; Liu PT
    Hong Kong Med J; 2008 Jun; 14(3):216-9. PubMed ID: 18525091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New B-type natriuretic peptide test (pro-BNP) for heart failure.
    Cardiovasc J S Afr; 2002; 13(5):272. PubMed ID: 12557877
    [No Abstract]   [Full Text] [Related]  

  • 5. ST2 and B-type natriuretic peptide kinetics during exercise in severe heart failure.
    Magini A; Farina S; Riggio D; Sandri MT; Agostoni P
    Eur J Heart Fail; 2018 Oct; 20(10):1494-1495. PubMed ID: 30052313
    [No Abstract]   [Full Text] [Related]  

  • 6. The diagnostic accuracy of the natriuretic peptides in heart failure: systematic review and diagnostic meta-analysis in the acute care setting.
    Roberts E; Ludman AJ; Dworzynski K; Al-Mohammad A; Cowie MR; McMurray JJ; Mant J;
    BMJ; 2015 Mar; 350():h910. PubMed ID: 25740799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of brain natriuretic peptide in the diagnosis of pediatric heart failure].
    Chen SB
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):722-4. PubMed ID: 17229368
    [No Abstract]   [Full Text] [Related]  

  • 8. Incremental prognostic value of changes in B-type natriuretic peptide in heart failure.
    Latini R; Masson S; Wong M; Barlera S; Carretta E; Staszewsky L; Vago T; Maggioni AP; Anand IS; Tan LB; Tognoni G; Cohn JN;
    Am J Med; 2006 Jan; 119(1):70.e23-30. PubMed ID: 16431191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides in heart failure.
    Lin DC; Diamandis EP; Januzzi JL; Maisel A; Jaffe AS; Clerico A
    Clin Chem; 2014 Aug; 60(8):1040-6. PubMed ID: 24700774
    [No Abstract]   [Full Text] [Related]  

  • 10. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.
    Daniels LB; Maisel A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):414-5. PubMed ID: 16721203
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid point-of-care NT-proBNP optimal cut-off point for heart failure diagnosis in primary care.
    Verdú JM; Comín-Colet J; Domingo M; Lupón J; Gómez M; Molina L; Casacuberta JM; Muñoz MA; Mena A; Bruguera-Cortada J
    Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):613-9. PubMed ID: 22541282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the role of B-type natriuretic peptide in detecting heart failure in critically ill, mechanically ventilated patients?
    Colombo R
    Minerva Anestesiol; 2009 Apr; 75(4):175-7. PubMed ID: 19308015
    [No Abstract]   [Full Text] [Related]  

  • 13. The relation between N-terminal pro-B-type natriuretic peptide and heart failure.
    Balta S; Demirkol S; Kucuk U; Unlu M; Arslan Z; Celik T
    Am J Emerg Med; 2013 Oct; 31(10):1533. PubMed ID: 24011587
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.
    Strunk A; Bhalla V; Clopton P; Nowak RM; McCord J; Hollander JE; Duc P; Storrow AB; Abraham WT; Wu AH; Steg G; Perez A; Kazanegra R; Herrmann HC; Aumont MC; McCullough PA; Maisel A
    Am J Med; 2006 Jan; 119(1):69.e1-11. PubMed ID: 16431187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
    Maisel AS; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Clopton P; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA;
    N Engl J Med; 2002 Jul; 347(3):161-7. PubMed ID: 12124404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of the levels of brain and atrial natriuretic peptides with the concentrations of inflammatory markers in patients with congestive heart failure].
    Orlova OV; Nadzhar MKh; Shevchenko OP
    Klin Lab Diagn; 2006 Aug; (8):9-14. PubMed ID: 17087239
    [No Abstract]   [Full Text] [Related]  

  • 17. CHF: effects of cardiac rehabilitation and brain natriuretic peptide.
    Ford CM; Pruitt R; Parker V; Reimels E
    Nurse Pract; 2004 Mar; 29(3):36-9. PubMed ID: 15021501
    [No Abstract]   [Full Text] [Related]  

  • 18. Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP.
    Bayes-Genis A; Barallat J; Galán A; de Antonio M; Domingo M; Zamora E; Gastelurrutia P; Vila J; Peñafiel J; Gálvez-Montón C; Lupón J
    Rev Esp Cardiol (Engl Ed); 2015 Dec; 68(12):1075-84. PubMed ID: 26297179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of brain natriuretic peptide measurements].
    Chen SB
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):743. PubMed ID: 17229374
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential costs of B-type natriuretic peptide for the identification of people with heart failure in primary care in Scotland - a pilot study.
    Chapman AR; Leslie SJ; Walker SW; Bickler C; Denvir MA
    J R Coll Physicians Edinb; 2015 Mar; 45(1):27-32. PubMed ID: 25874827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.